A real-world comparison of the effectiveness and safety of vedolizumab and anti-TNF therapies in early treatment initiation with first-line biologic therapy in ulcerative colitis: Results from EVOLVE

被引：0
|
作者：
Mantzaris, G. [1 ]
Bressler, B. [2 ]
Kopylov, U. [3 ]
Bassel, M. [4 ]
Brett, N. [4 ]
Colby, C. [5 ]
Lopez, C. [6 ]
Saha, S. [7 ]
Kifnidi, C. [8 ]
Agboton, C. [9 ]
Adsul, S. [9 ]
Demuth, D. [10 ]
Luo, M. [11 ]
Wang, S. [11 ]
Yarur, A. [12 ]
机构：
[1] Evangelismos Med Ctr, Dept Gastroenterol, Athens, Greece
[2] St Pauls Hosp, Dept Gastroenterol, Vancouver, BC, Canada
[3] Sheba Med Ctr, Dept Gastroenterol, Tel Aviv, Israel
[4] Evidera, Real World Evidence, Montreal, PQ, Canada
[5] Evidera, Real World Evidence, San Francisco, CA USA
[6] Takeda Pharmaceut USA Inc, Dept Med Affairs, Deerfield, IL USA
[7] Takeda Canada Inc, Dept Med Affairs, Oakville, ON, Canada
[8] Takeda Hellas SA Athens, Dept Med Affairs, Athens, Greece
[9] Takeda Pharmaceut Int AG, Dept Global Med Affairs, Zurich, Switzerland
[10] Takeda Pharmaceut Int, Evidence Generat & Publicat, Singapore, Singapore
[11] Takeda Pharmaceut Int, Global Outcomes Res, Boston, MA USA
[12] Med Coll Wisconsin, Dept Gastroenterol, Milwaukee, WI 53226 USA
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
DOP55
引用
收藏
页码：S092 / S094
页数：3
相关论文
共 50 条
  • [31] Real-life comparison of different anti-TNF biologic therapies for ulcerative colitis treatment: A retrospective cohort study
    Barberio, B.
    Zingone, F.
    D'Inca, R.
    Marinelli, C.
    Maccarone, M. C.
    Gubbiotti, A.
    Cingolani, L.
    Lorenzon, G.
    Ghisa, M.
    Savarino, E. V.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S548 - S549
  • [32] REAL-WORLD COMPARISON OF LONG-TERM DRUG SURVIVAL OF FIRST-LINE BIOLOGIC AGENTS FOR ULCERATIVE COLITIS
    Dalal, Rahul S.
    McClure, Emma L.
    Marcus, Jenna
    Allegretti, Jessica R.
    GASTROENTEROLOGY, 2022, 162 (07) : S605 - S606
  • [33] Effectiveness and safety of anti-TNF therapy for ankylosing spondylitis: a real-world study
    Komel Pimenta, Pedro Ricardo
    Ribeiro da Silva, Michael Ruberson
    Ribeiro dos Santos, Jessica Barreto
    Kakehasi, Adriana Maria
    Assis Acurcio, Francisco de
    Alvares-Teodoro, Juliana
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 10 (06) : 509 - 517
  • [34] Adalimumab as first-line anti-TNF treatment in ulcerative colitis. A "real-life" observational study
    Lorente, R.
    Verdejo, C.
    Roncero, O.
    Lopez, D.
    Robledo, P.
    Bouhmidi, A.
    Hervias, D.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S280 - S280
  • [35] Vedolizumab as first line biologic therapy in elderly patients with contraindications against anti-TNF therapy - A real-world nationwide cohort of patients with inflammatory bowel diseases
    Attauabi, M.
    Hoglund, C.
    Fassov, J.
    Pedersen, K. B.
    Hansen, H. Bansholm
    Wildt, S.
    Jensen, M. Dam
    Neumann, A.
    Lind, C.
    Jacobsen, H. Albaek
    Popa, A. M.
    Kjeldsen, J.
    Pedersen, N.
    Molazahi, A.
    Haderselv, K.
    Aalykke, C.
    Knudsen, T.
    Cebula, W.
    Munkholm, P.
    Bendtsen, F.
    Seidelin, J. B.
    Johan, B.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S369 - S370
  • [36] Vedolizumab: First-line Biologic for Ulcerative colitis and Crohn's Disease Real-world Data shows continued stable Disease Progression
    Ruedesheim, Sabine M.
    VISCERAL MEDICINE, 2023, 39 (3-4) : 100 - 100
  • [37] Treatment persistence of first-line anti-TNF therapy in patients with inflammatory bowel diseases: results from a real-world study over 20 years
    Blesl, A.
    Binder, L.
    Hogenauer, C.
    Wenzl, H.
    Borenich, A.
    Pregartner, G.
    Berghold, A.
    Mestel, S.
    Kump, P.
    Baumann-Durchschein, F.
    Petritsch, W.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 : S427 - S428
  • [38] BIOLOGIC THERAPY SEQUENCING IN ULCERATIVE COLITIS: A REAL-WORLD OBSERVATIONAL STUDY OF SECOND-LINE THERAPY AFTER VEDOLIZUMAB
    Anyanwu, Precious A.
    Fernandes, Christopher
    Van Anglen, Lucinda J.
    Chou, Chiahung
    Sanchirico, Marie
    Sarles, Harry
    Chapman, Casey
    Jiang, Jeanne
    Fan, Tao
    Young, Lisa
    Ritter, Timothy
    GASTROENTEROLOGY, 2024, 166 (05) : S1147 - S1148
  • [39] Biologic Therapy Sequencing in Ulcerative Colitis: A Real-World Observational Study of Second-Line Therapy After Vedolizumab
    Fernandes, Christopher
    Anyanwu, Precious A.
    Van Anglen, Lucinda J.
    Sarles, Harry
    Chapman, Casey
    Chou, Chiahung
    Jiang, Jeanne
    Sanchirico, Marie
    Fan, Tao
    Young, Lisa
    Ritter, Timothy
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (12S) : S40 - S40
  • [40] Real-World Treatment Outcomes Associated With Early Versus Delayed Vedolizumab Initiation in Patients With Ulcerative Colitis
    Cleveland, Noa Krugliak
    Candela, Ninfa
    Carter, John A.
    Kuharic, Maja
    Qian, Joyce
    Tang, Zhaoli
    Turpin, Robin
    Rubin, David T.
    CROHNS & COLITIS 360, 2024, 6 (04)
12345